Notable Moves: Staples (NASDAQ:SPLS), Amgen Inc. (NASDAQ:AMGN), Heartware International Inc. (NASDAQ:HTWR), Essex Property Trust Inc. (NYSE:ESS), Bio-Path Holdings (NASDAQ:BPTH)


Staples, Inc. (NASDAQ:SPLS) will reject plea from 6 percent shareholder Starboard Value LP to combine with Office Depot Inc according to a Tuesday. On Tuesday shares of Staples, Inc. (NASDAQ:SPLS) closed at $16.39. Company’s EPS growth for next 5 years is recorded as -3.34%.

Biotech drugmaker Amgen Inc. (NYSE: AMGN), based in Thousand Oaks, California, and the Colorado BioScience Association backed the doctor-notification requirement for biosimilars last time the bill was tried, saying it would help safeguard patients. Amgen Inc. (NASDAQ:AMGN) in last trading activity fell -0.52% to close at $157.60. Company weekly performance is 0.88% while its quarterly performance stands at 18.34%. Amgen Inc. (NASDAQ:AMGN) is -8.98% away from its 52 week high.

HeartWare International, Inc. (NASDAQ:HTWR) recently announced preliminary top-line results for fourth quarter and full year 2014. The company expects to report complete fourth quarter and full-year 2014 financial results in late Feb 2015.On last trading day Heartware International Inc. (NASDAQ:HTWR) moved up 0.57% to close at $80.75. Its volatility for the week is 2.29% while volatility for the month is 2.83%. HTWR’s sales growth for past 5 years was 270.00% and its EPS growth for past 5 years was -4.20%. Heartware International Inc. (NASDAQ:HTWR) monthly performance is 11.38%.

Essex Property Trust Inc. (NYSE:ESS)’s CEO Michael J. Schall sold 8,000 shares of the company’s stock on the open market in a transaction that occurred on Wednesday, January 7th. The stock was sold at an average price of $216.25, for a total transaction of $1,730,000.00. Essex Property Trust Inc. (NYSE:ESS) has 0.10% insider ownership while its institutional ownership stands at 75.50%. In last trading activity company’s stock closed at $226.11.

Stock analysts at Maxim Group set a $5.00 price objective on shares of Bio-Path Holdings (NASDAQ:BPTH) stock in a report issued on Wednesday, 7 January 2015. The firm currently has a a “buy” rating on the stock. On last trading day Bio-Path Holdings, Inc. (NASDAQ:BPTH) fell -0.84% to close at $2.35. Its volatility for the week is 5.57% while volatility for the month is 4.64%. BPTH’s EPS growth for past 5 years was 6.50%. Bio-Path Holdings, Inc. (NASDAQ:BPTH) monthly performance is -11.99%.


Leave a Reply

Your email address will not be published. Required fields are marked *